Devyser Diagnostics AB publishes Interim Report for the period, January to September 2021
Continued focus on increased direct sales "The second half of the year started off very well for Devyser. Sales remained strong during the quarter, and operations continued to develop in accordance with plans, with a continued focus on increasing the share of direct sales in Europe and building a presence in the US. The effects of the pandemic are decreasing with every passing month, even though we continue to see some limitations in access to current and new customers in certain parts of Asia.” Fredrik Alpsten, CEO Third Quarter, July - September 2021 · Net sales amounted to SEK